Leadership team

Merav is a seasoned regulatory affairs professional with over 30 years of experience in the pharmaceutical industry. As Senior Vice President of Pharmacovigilance, Medical Information, and Regulatory Affairs at Clinigen, she leads a global team dedicated to ensuring patient safety and regulatory affairs strategy and submissions, overseeing the Clinigen Lifecycle Services business unit.

Trained as a pharmacist with a master’s degree in Biopharmacy from King’s College London, Merav brings a deep understanding of drug development and lifecycle management. Having joined Clinigen in 2014, her expertise is instrumental in guiding Clinigen’s global projects through complex regulatory landscapes.

Merav is passionate about building high-performing teams and fostering a culture of excellence. Under her leadership, the Clinigen team delivers exceptional pharmacovigilance, medical information, and regulatory support to clients worldwide.

Nihad Hasagic is the Senior Vice President, Lifecycle Services at Clinigen, joining the company in December 2023. Previously, as SVP of Strategic Initiatives for Clinigen, Nihad was pivotal in successful acquisitions and the development of the company's core growth strategy, including his foundational work in launching Clinigen Lifecycle Services and shaping its commercial strategy.

Nihad has spent over 20 years in the Healthcare, Life Science and Specialty Chemicals industry working for Monitor, Ecolab and Arxada in various roles and functions having General Management and P&L responsibility, leading multiple acquisitions and integrations, and building and implementing various strategic marketing and corporate initiatives.

Nihad holds a Master of Electrical Engineering from the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland, and an MBA from Cranfield School of Business in the UK.

Mike is a co-founder of Ascenian Consulting, which was acquired by Clinigen in 2024. He’s responsible for commercial strategy. Mike has over 20 years of experience in healthcare, including five in US federal health policy and 15+ in commercial strategy and access consulting. Prior to Ascenian, Mike was a senior Principal, Global Market Accessing Consulting, at PPD / Evidera, and Director of Commercial Strategy and Reimbursement at United BioSource Corporation. Mike holds a MS in public policy analysis and BA magna cum laude in political science from University of Rochester. He is based in New York.